Loading organizations...

§ Venture Capital · Boston, MA, USA
early-stage venture capital firm investing in enterprise technology startups: cybersecurity, digital health, data & AI, cloud infrastructure.
.406 Ventures is an early-stage venture capital firm that invests in innovative enterprise technology startups and is headquartered in Boston, Massachusetts. The organization manages over $1.4 billion in assets under management across multiple investment vehicles, backing a diverse portfolio of 98 companies that operate primarily within the cybersecurity, digital health, cloud infrastructure, and artificial intelligence sectors. In early 2024, the firm successfully closed its fifth flagship fund with $265 million in capital commitments secured from a variety of limited partners, including university endowments, foundations, and pension plans. Its historical and current investment portfolio features several notable enterprise and healthcare technology companies, including recognized industry names such as Carbon Black, Veracode, Iora Health, and Shazam. The firm was originally founded in 2005 by experienced industry operators Liam Donohue, Larry Begley, and Maria Cirino.
Key people at .406 Ventures.
Key people at .406 Ventures.
# .406 Ventures: Building Category-Defining Companies Through Deep Partnership
.406 Ventures is a Boston-based early-stage venture capital firm that has spent nearly two decades proving that exceptional returns come from exceptional relationships[4]. Founded in 2005, the firm manages over $1.3 billion in capital and operates with a singular mission: to partner with visionary entrepreneurs building game-changing companies in healthcare, data and AI, and cybersecurity[1][5].
The firm's investment philosophy centers on operational centricity and hands-on partnership rather than passive capital deployment. .406 Ventures typically leads Series A rounds, investing between $2 million and $5 million initially with substantial reserves for follow-on support[1]. What distinguishes the firm is its conviction that early-stage companies need far more than capital—they need strategic guidance, operational expertise, and access to deep industry networks. This approach has resulted in 94 portfolio companies employing approximately 8,000 people, with notable exits including AbleTo, Carbon Black, CloudHealth Technologies, and Iora Health[5].
.406 Ventures was established in late 2005 by Larry Begley, Maria Cirino, and Liam Donohue, three seasoned operators and investors who set out to build the kind of venture firm they wished had existed when they were founders themselves[5]. The founding team deliberately constructed an investment approach grounded in real-world experience and "scar tissue"—the hard-won lessons that come from actually building companies in competitive markets.
The firm's founding tenants have remained remarkably consistent over nearly two decades: operational centricity, early-stage focus on Series A investments, and geographic concentration on East Coast opportunities[3]. What has evolved is the team composition and depth of domain expertise. The firm has organically built an investment team that is predominantly female—a notable differentiator in an industry historically dominated by male investors[3]. Recent additions including Payal, Kathryn, Kevin, Eliza, and Joey have expanded the firm's capabilities while maintaining its core identity[3].
Operational Expertise as Core Competency — Every team member brings operational experience from building and scaling companies[3]. This isn't theoretical knowledge; it's lived experience navigating the exact challenges their portfolio companies face. This operational centricity informs both investment decisions and the quality of support provided post-investment[3].
Strategic Timing in the Investment Lifecycle — The firm focuses specifically on Series A investments, a stage where companies have demonstrated early product-market fit but still have substantial building ahead[3]. This positioning allows .406 to add disproportionate value at a critical inflection point, materially impacting growth trajectories in ways that later-stage investors cannot[6].
Deep Domain Specialization — Rather than pursuing broad technology investing, .406 concentrates on three sectors where the team possesses genuine expertise: healthcare, data and cloud infrastructure, and cybersecurity[3][6]. This focus enables the firm to identify nuanced opportunities and provide sector-specific guidance that generalist investors cannot match.
Repeat Founder Relationships — The firm has cultivated a remarkable track record of repeat engagement, with over 20% of its portfolio comprising entrepreneurs who have worked with .406 multiple times[5]. This metric—17 founders returning to build second companies with the firm—reflects the quality of partnership and trust the firm has earned[5].
East Coast Concentration with Selective Expansion — While approximately one-third of the portfolio operates outside the Northeast, .406 maintains strategic focus on East Coast opportunities where it can develop deep local networks and provide hands-on support[3]. This geographic discipline prevents the dilution that comes from trying to support companies across multiple regions.
.406 Ventures operates at a critical juncture in the venture capital ecosystem. The firm's three focus areas—healthcare technology, data and AI infrastructure, and cybersecurity—represent some of the most consequential technology trends reshaping enterprise software and digital health.
The firm's emphasis on operational support and founder partnership reflects a broader market recognition that capital alone has become commoditized. In an era where early-stage companies can access funding from numerous sources, the scarcest resource is experienced guidance and strategic networks. .406's model—delivering "scar tissue, late-night brainstorming sessions, and early-morning navigation of challenges"—addresses this reality[5].
The firm's success in building a predominantly female investment team also positions it to identify and support founders who might be overlooked by more traditional venture firms. This diversity of perspective likely contributes to the firm's ability to spot category-defining opportunities that others miss.
Additionally, .406's track record of successful exits and repeat founder relationships creates a virtuous cycle: successful exits generate returns for limited partners, which enables larger fund sizes; repeat founders bring proven track records and deeper relationships with the firm, reducing investment risk; and the firm's reputation attracts higher-quality deal flow. This ecosystem effect amplifies the firm's influence beyond its direct capital deployment.
.406 Ventures has built something increasingly rare in venture capital: a durable, values-driven firm that has maintained its core philosophy while scaling meaningfully. The firm's $1.3 billion under management and 94 portfolio companies represent substantial influence, yet the firm has resisted the pressure to become a generalist mega-fund.
Looking forward, several trends will likely shape .406's trajectory. First, the continued importance of operational support in early-stage investing will validate the firm's core model. As AI and data infrastructure become increasingly critical to enterprise competitiveness, .406's deep expertise in these domains positions it well. Second, the firm's emphasis on repeat founders suggests a potential evolution toward building a more concentrated portfolio of serial entrepreneurs, potentially increasing returns through deeper partnership.
The firm's geographic focus on the East Coast, while potentially limiting in a venture world obsessed with Silicon Valley, may prove prescient as technology talent and innovation increasingly distribute across regions. Boston's strength in healthcare, cybersecurity, and data infrastructure aligns perfectly with .406's thesis.
Ultimately, .406 Ventures represents a counterpoint to the venture capital industry's tendency toward scale and commoditization. By remaining operationally centered, sector-focused, and genuinely committed to founder partnership, the firm has created a sustainable competitive advantage. In an industry where relationships are often transactional, .406's ability to earn the trust of founders—evidenced by repeat engagement and strong exits—suggests the firm will continue to generate outsized returns while building genuinely transformative companies.
.406 Ventures has more than 26 tracked investments across 24 companies. The latest tracked deal is $23.7M Venture Round in Big Health in February 2026.